Bio & Insurance Information

Dr. Joanne Weidhass is a board-certified radiation oncologist based in Los Angeles, California. She graduated from the Tufts University School of Medicine and then did her internship at the Caritas Carney Hospital. She pursued her Radiation Oncology residency at the Memorial Sloan-Kettering Cancer Center. Dr. Weidhaas has been practicing for about two decades and is currently affiliated with the Lawrence and Memorial Hospital, Yale-New Haven Hospital, UCLA Medical Center, and Bridgeport Hospital. She has also authored several research papers.


Insurance Accepted

Medicare


Education & Training

Tufts University

Medical School

Caritas Carney Hospital

Internship

Memorial Sloan-Kettering Cancer Center

Residency

Board Certifications

American Board of Radiology - Radiation Oncology

Medical License

CA State Medical License 2015 - 2017

CT State Medical License 2004 - 2017

Hospitals & Clinics

Bridgeport Hospital

Languages: English/Spanish

(203) 384-3000

267 Grant St

Bridgeport, Connecticut 06610

Read More

Lawrence + Memorial Hospital

Languages: English/Spanish

(860) 442-0711

365 Montauk Ave

New London, Connecticut 06320

Read More

University of California - Los Angeles Medical Center

Languages: English/Spanish

(310) 794-7953

10833 Le Conte Ave

Los Angeles, California 90095

Read More

Yale-New Haven Hospital

Languages: English/Spanish

(203) 688-4242

20 York St.

New Haven, Connecticut 06510

Read More

Publications

Dr. Joanne Weidhaas has contributed to 3 publications.

cel-mir-237 and its homologue, hsa-miR-125b, modulate the cellular response to ionizing radiation.

Metheetrairut, C.,Adams, B. D.,Nallur, S.,Weidhaas, J. B.,Slack, F. J.; Oncogene. 2016 Jun 21.

See more >>

A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Chung, C. H.,Lee, J. W.,Slebos, R. J.,Howard, J. D.,Perez, J.,Kang, H.,Fertig, E. J.,Considine, M.,Gilbert, J.,Murphy, B. A.,Nallur, S.,Paranjape, T.,Jordan, R. C.,Gar...; Ann. Oncol.. 2014 Aug 02.

See more >>

Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer.

Chen, X.,Paranjape, T.,Stahlhut, C.,McVeigh, T.,Keane, F.,Nallur, S.,Miller, N.,Kerin, M.,Deng, Y.,Yao, X.,Zhao, H.,Weidhaas, J. B.,Slack, F. J.; Oncogene. 2014 Jun 10.

See more >>